Aliskiren and amlodipine in the management of essential hypertension: meta-analysis of randomized controlled trials.
<h4>Background</h4>Aliskiren is a novel renin-angiotensin aldosterone system (RAAS) inhibitor, the combination therapy of aliskiren and amlodipine for blood pressure control have been reported recently. The primary objective of this analysis is to review recently reported randomized cont...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2013
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ac1000c01c4f417ab5757b0ddd8bb03f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|